Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder.
Phase of Trial: Phase IV
Latest Information Update: 27 Sep 2016
At a glance
- Drugs Ziprasidone (Primary)
- Indications Bipolar disorders
- Focus Therapeutic Use
- 21 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 01 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 May 2012 Planned end date changed from 1 Apr 2012 to 1 Aug 2012 as reported by ClinicalTrials.gov.